By Mill Chart
Last update: May 8, 2024
Our stock screener has singled out INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) as a stellar value proposition. NASDAQ:IART not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. We'll explore this further.
ChartMill provides a Valuation Rating to every stock, ranging from 0 to 10. This rating assesses various valuation aspects, comparing price to earnings and cash flows, while considering factors like profitability and growth. NASDAQ:IART boasts a 8 out of 10:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:IART was assigned a score of 7 for profitability:
ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:IART scores a 5 out of 10:
Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:IART boasts a 4 out of 10:
Our Decent Value screener lists more Decent Value stocks and is updated daily.
Check the latest full fundamental report of IART for a complete fundamental analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
INTEGRA LIFESCIENCES HOLDING
NASDAQ:IART (5/17/2024, 7:05:03 PM)
After market: 27.54 0 (0%)27.54
+0.05 (+0.18%)
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
Investors should take notice ofINTEGRA LIFESCIENCES HOLDING (NASDAQ:IART)—it offers a great deal for the fundamentals it presents.
Which stocks are moving on Monday?
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
IART stock results show that Integra Lifesciences met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
The Integra LifeSciences' CereLink ICP Monitoring System will be highlighted in booth #655 at AANS Annual Meeting in Chicago, Illinois....
PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology...